NCT06741644 2026-01-09
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
CStone Pharmaceuticals
Phase 1/2 Recruiting
CStone Pharmaceuticals
HRYZ Biotech Co.
EMD Serono
Gilead Sciences
Hansoh BioMedical R&D Company
AstraZeneca
OSI Pharmaceuticals